Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our congratulations go to Dr Richard Colling from the Nuffield Department of Surgical Sciences (NDS) who has been elected to a Junior Research Fellowship (JRF) at Kellogg College in Oxford.

Dr Colling is a Senior Clinical Research Fellow in Cellular Pathology (Histopathology) and a key area of his work is in developing the use of digital pathology tools, machine learning and image analysis for use in clinical practice. Working on the Innovate UK PathLAKE project at the Oxford Centre, he is collaborating with a multidisciplinary team on digital pathology in the Verrill Pathology Group at NDS.

The main duty of the Junior Research Fellow is to undertake research, however it is hoped that the JRF will also contribute to the general intellectual life of Kellogg College. Dr Colling is looking forward to the opportunity to be involved with outreach, social and academic events, and other activities at the College and network with more medics and academics across the University. He will also be acting as a College Advisor to a number of graduate students.

Commenting on his appointment, which takes effect from October 2019, Dr Colling said: “I am delighted to have been elected to a JRF at Kellogg. Being a College JRF will give me the opportunity to meet and share ideas with academics, researchers and students from across the wider University. I hope I will be able to act as a bridge between NDS and the College and help spread the word about what we are doing with digital pathology in Oxford.”

Read more about Dr Richard Colling.

 

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.